Methotrexate

About

Therapy type: Chemotherapy

Therapy strategy: Antifolate

Mappings

NCI Thesaurus: Methotrexate (coding:ncit:C642)

RxNorm: methotrexate (coding:rxcui:6851, coding:omop:1305058)

SNOMED: Methotrexate (coding:sctid:387381009, coding:omop:4301206)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
EMA (1) FDA (1) BCR::ABL1 Acute Lymphoid Leukemia Cytarabine, Dexamethasone, Methotrexate, Ponatinib, Prednisone, Vincristine
EMA (1) CD20 + Diffuse Large B-Cell Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Non-Hodgkin Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Burkitt Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
HSE (1) BCR::ABL1 Acute Lymphoid Leukemia Daunorubicin, Dexamethasone, Imatinib, Methotrexate, Vincristine
HSE (1) BCR::ABL1, CD20 + Acute Lymphoid Leukemia Daunorubicin, Dexamethasone, Imatinib, Methotrexate, Rituximab, Vincristine
HSE (1) CD20 + Acute Lymphoid Leukemia Daunorubicin, Dexamethasone, Methotrexate, Rituximab, Vincristine